Kala Bio KALA
NASDAQ KALA
$0.56 +0.00 (+0.00%)
As of: Sep 10, 2026 · 2:47 PM EDT

Kala Bio (KALA) Price to Book (2017 - 2026)

Kala Bio's (KALA) quarterly Price to Book came in at 2.92 in Q2 2026, up 100.59% year-over-year from 1.46 in Q2 2025, and down 69.36% quarter-over-quarter from 9.54 in Q1 2026.

Analysis

Kala Bio (KALA) Price to Book (2017 - 2026) Analysis & Trends

Kala Bio has disclosed Price to Book across 10 years of filings, most recently posting 2.92 for Q2 2026.

  • In Q2 2026, Price to Book rose 100.59% year-over-year to 2.92; the TTM figure through Jun 2026 stood at 2.92 (up 100.59% YoY), while the FY2025 annual figure was 32.38, down 69.69% from the prior year.
  • Price to Book came in at 2.92 for Q2 2026 at Kala Bio, down from 9.54 in the prior quarter.
  • In the past five years, Price to Book ranged from a high of 323.86 in Q1 2025 to a low of 956.1 in Q1 2022.
  • Average Price to Book over 5 years is 49.68, with a median of 76.19 recorded in 2023.
  • Year-over-year, Price to Book surged 403.86% in 2023 and plunged 733.14% in 2025.
  • Over 5 years, Price to Book stood at 171.61 in 2022, then decreased by 25.0% to 128.7 in 2023, then slipped by 17.01% to 106.81 in 2024, then tumbled by 69.69% to 32.38 in 2025, then sank by 90.97% to 2.92 in 2026.
  • Per Business Quant data, the three most recent Price to Book figures were 2.92 in Q2 2026, 9.54 in Q1 2026, and 32.38 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 206.55 Bn 192.56 Bn 7.24 Bn
2 Gilead Sciences 180.15 Bn 176.98 Bn 6.22 Bn
3 Vertex Pharmaceuticals 131.59 Bn 123.73 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 81.98 Bn 73.98 Bn 3.93 Bn
5 Argenx Se 60.33 Bn 55.14 Bn 1.37 Bn
6 Moderna 53.75 Bn 48.61 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.06 Bn 29.76 Bn 992.69 Mn
8 Biogen 31.95 Bn 30.67 Bn 1.96 Bn
9 Roivant Sciences 29.25 Bn 29.25 Bn 1.16 Mn
10 Kala Bio 8.44 Mn 8.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.92
Mar 31, 2026 9.54
Dec 31, 2025 32.38
Sep 30, 2025 -65.62
Jun 30, 2025 -495.83
Mar 31, 2025 323.86
Dec 31, 2024 106.81
Sep 30, 2024 191.56
Jun 30, 2024 78.31
Mar 31, 2024 168.50
Dec 31, 2023 128.70
Sep 30, 2023 106.78
Jun 30, 2023 105.88
Mar 31, 2023 74.07
Dec 31, 2022 171.61
Sep 30, 2022 -842.81
Jun 30, 2022 -34.84
Mar 31, 2022 -956.10
Dec 31, 2021 235.82
Sep 30, 2021 140.03